ConductScience.org, home

Paper4512950

Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.

Van Putten LM and 2 others. Cancer Chemother Rep, 1972. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Cell-cycle specificity and therapeutic effectiveness of cytostatic agents. Papers, record 4512950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4512950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.
PubMed
Journal
Cancer Chemother Rep
PubMed
Year
1972
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
3.02
iCite
Revised in PubMed
2016-06-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Putten LML M
2Lelieveld PP
3Kram-Idsenga LKL K

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cell DivisionMajor topic
Animals
Dose-Response Relationship, Drug
Hematopoietic Stem Cells
Male
Mice
Mice, Inbred C57BL
Mice, Inbred CBA
Neoplasms, Experimental
Osteosarcoma

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
42098761Effects of gallic acid on cyclophosphamide-induced experimental ovarian injury in rats.BMC Womens Health2026https://conductscience.org/library/papers/42098761PubMed
14730338Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma.Bone Marrow Transplant2004https://conductscience.org/library/papers/14730338PubMed
6889884Effects of cisplatin on different haemopoietic progenitor cells in mice.Br J Cancer1982https://conductscience.org/library/papers/6889884PubMed
6758828Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.Br J Cancer1982https://conductscience.org/library/papers/6758828PubMed
6469516Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in mice.Invest New Drugs1984https://conductscience.org/library/papers/6469516PubMed
6453124Comparison of cytostatic sensitivities of L 1210 cells and human stimulated lymphocytes in three cell proliferation assays.J Cancer Res Clin Oncol1980https://conductscience.org/library/papers/6453124PubMed
4053268Protective effect of testosterone or 5 beta-dihydrotestosterone pretreatment on CFU-E numbers in busulfan-treated rabbits.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4053268PubMed
4017168Dose-response curves after in vivo experimental chemotherapy: influence of route of administration on biological outcomes.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4017168PubMed
3470163Changing metastatic patterns of a transplantable rat osteosarcoma.Clin Exp Metastasis1987https://conductscience.org/library/papers/3470163PubMed
33031105-Fluorouracil treatment after irradiation impairs recovery of bone marrow functions.Radiat Environ Biophys1987https://conductscience.org/library/papers/3303110PubMed
3049432
In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. typhimurium.
Invest New Drugs1988https://conductscience.org/library/papers/3049432PubMed
1419625Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.Br J Cancer1992https://conductscience.org/library/papers/1419625PubMed
1207290[Chemotherapy of cancer: the present status (author's transl)].Langenbecks Arch Chir1975https://conductscience.org/library/papers/1207290PubMed
1156523Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.Br J Cancer1975https://conductscience.org/library/papers/1156523PubMed
638016Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents.Br J Cancer1978https://conductscience.org/library/papers/638016PubMed
119584Ftorafur: a self-limiting source of 5-fluorouracil?Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/119584PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4512950

GET https://conductscience.org/api/papers/v1/4512950/authors